Neuronetics (STIM) Operating Expenses (2017 - 2026)

Neuronetics (STIM) has 10 years of Operating Expenses data on file, last reported at $25.1 million in Q1 2026.

• On a quarterly basis, Operating Expenses fell 5.99% year-over-year to $25.1 million in Q1 2026; TTM through Mar 2026 was $102.1 million, a 6.92% increase from a year earlier, with the FY2025 full-year figure at $103.7 million, up 16.93% from the prior year.
• Operating Expenses for Q1 2026 stood at $25.1 million, down from $26.7 million in the prior quarter.
• Over the last five years, Operating Expenses for STIM reached as high as $26.8 million in Q1 2025 and fell as low as $19.9 million in Q1 2024.
• Historically, Operating Expenses has averaged $22.6 million across 5 years, with a median of $21.5 million in 2022.
• Across the five-year window, Operating Expenses dropped 8.89% in 2023 and jumped 34.12% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $21.5 million in 2022, then retreated by 6.21% to $20.2 million in 2023, then jumped by 30.53% to $26.4 million in 2024, then grew by 1.45% to $26.7 million in 2025, then slipped by 5.97% to $25.1 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $25.1 million in Q1 2026, $26.7 million in Q4 2025, and $24.4 million in Q3 2025.